抗Caspr1抗体自身免疫性结病临床、电生理与病理特征
该研究纳入559例CIDP患者血清,鉴定出19例抗Caspr1 IgG阳性,以IgG4亚型为主。IgG4型患者起病年龄较晚、男性多见、临床表现为肢体无力、步态障碍、震颤和感觉性共济失调,脑脊液蛋白显著升高。神经传导显示F波及远端运动潜伏期延长、传导速度减慢;腓肠神经活检示有髓纤维密度降低、髓鞘卵圆体及轴突-胶质分离。IgG4型对IVIg反应差,抗体滴度随临床改善而下降。
要点
- 抗Caspr1 IgG4结病起病年龄较晚,以男性为主,突出表现为感觉性共济失调和震颤。
- 电生理示F波和远端运动潜伏期延长、传导速度减慢;病理见轴突-胶质分离。
- IgG4型对IVIg反应差,常需联合免疫治疗;抗体滴度可能反映疾病活动度。
核心结论
- IgG4抗Caspr1自身免疫性结病具有与其他结病相似但起病年龄更晚的临床表型。
- 抗体滴度变化可能作为监测疾病活动的潜在生物标志物。
研究设计与样本
- 回顾性研究,纳入全国559例符合EFNS/PNS电生理诊断标准的CIDP患者连续血清样本。
- 采用in-house ELISA筛查抗Caspr1 IgG,并经免疫组化和Western blotting确认。
- 回顾性收集临床资料、电生理及治疗反应,并检查腓肠神经病理。
- 分析基线及随访时INCAT残疾评分、抗体滴度和血清NfL水平。
主要发现
- 559例CIDP患者中鉴定出19例抗Caspr1 IgG阳性,主要亚型为IgG4(17例)。
- IgG4型患者起病年龄中位数67岁,男性占82%,肢体无力及步态障碍均占100%,震颤占65%,感觉性共济失调占82%。
- 脑脊液蛋白水平很高(249 mg/dL)。
- 神经传导研究显示所有受试神经F波和远端运动潜伏期延长、感觉运动传导速度减慢。
- 4例腓肠神经活检光镜示有髓纤维密度降低和髓鞘卵圆体,无巨噬细胞介导的脱髓鞘或洋葱球;电镜示轴突-胶质分离。
临床怎么用
- 对CIDP患者,尤其起病年龄晚、男性、伴感觉性共济失调和震颤者,应检测抗Caspr1抗体。
- IgG4型抗Caspr1结病患者对IVIg反应差,应考虑联合免疫治疗。
- 抗体滴度变化可能用于监测疾病活动度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The significance of anti-contactin-associated protein 1 (Caspr1) antibodies in autoimmune nodopathies (ANs) has not been fully established. The aim of this study was to elucidate the clinical profiles of Caspr1 AN. METHODS: Consecutive serum samples were included from patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) nationwide who were referred to our laboratory for antibody testing with questionnaires as part of routine clinical practice and who fulfilled definite European Federation of Neurological Societies and Peripheral Nerve Society electrodiagnostic criteria. Anti-Caspr1 immunoglobulin (Ig) G was screened using in-house ELISA and confirmed using immunohistochemistry and Western blotting. Clinical data, electrophysiologic findings, and treatment responses were retrospectively collected. The pathologic features of sural nerves were also examined. Inflammatory Neuropathy Cause and Treatment (INCAT) disability scores, antibody titers, and serum neurofilament light chain (NfL) levels were analyzed at baseline and follow-up. RESULTS: Of 559 screened serum samples from patients with CIDP (median age at onset 54 years, 35% female), 19 cases with anti-Caspr1 IgG were identified; the main subclass was IgG4 (17 cases). Patients with IgG4 Caspr1 AN cases exhibited an older age at disease onset (median 67 years); male predominance (82%); high proportions of limb weakness (100%), gait disturbance (100%), tremor (65%), and sensory ataxia (82%); and very high CSF protein levels (249 mg/dL). Nerve conduction studies showed prolonged F-wave and distal motor latencies and reduced sensorimotor conduction velocities in all nerves tested. Light microscopy findings of sural nerve biopsy specimens from 4 patients with Caspr1 AN indicated a loss of myelinated fiber density and myelin ovoids without macrophage-mediated demyelination or onion bulbs. Electron microscopic evaluation demonstrated axo-glial detachment. Patients with IgG4 Caspr1 AN showed a poor response to IVIg (31%) and needed combined immunotherapies. Even after correcting for age, serum NfL levels were higher in patients with IgG4 Caspr1 AN than in healthy controls (p = 0.0609) and correlated with INCAT scores (p = 0.0143). In the 7 patients with 2 consecutive serum samples, antibody titers decreased with clinical improvement. DISCUSSION: IgG4 Caspr1 AN presents with a similar clinical phenotype to other nodopathies (e.g., neurofascin 155 and contactin 1), but with an older age at onset. Changes in antibody titers may be a potential biomarker for monitoring disease activity.
引用
- Tashiro T, Ogata H, Fukami Y, et al. Clinical, Electrophysiologic, and Pathologic Features of Anti-Contactin-Associated Protein 1 Autoimmune Nodopathy. Neurology. 2025. PMID: 41052376. doi:10.1212/WNL.0000000000214143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。